Results 1-1 of 1
User Review - Flag as inappropriate

Eli Lilly Enzastaurin two experimental drugs a significant effect of brain tumors
Indianapolis manufacturer Eli Lilly (LLY) Tuesday reported an initial Phase II clinical trial results showed
recurrent glioblastoma multiforme tumor (glioblastoma multiforme) in patients with the condition after <a href="">Enzastaurin</a> oral medication significantly improved, side pole small. Recurrent glioblastoma multiforme tumor is a brain tumor.
Medchemexpress Can provide the above product,its website:<a href=""></a>
<a href="">VX-745</a>
<a href="">TAK-715</a>
<a href="">SB 239063</a>
<a href="">SD-06</a>
<a href="">Vinorelbine</a>
<a href="">LY2228820</a>
<a href="">PD0325901</a>
<a href="">Trametinib</a>
<a href="">GSK1120212 DMSO solvate</a>
<a href="">PD98059</a>

5 stars - 0
4 stars - 0
3 stars - 0
2 stars - 0
1 star - 0

Editorial reviews - 0
User reviews - 1